Peter H Ross

US Patent:

52376508, Aug 17, 1993

Filed:

Dec 20, 1991

Appl. No.:

7/814189

Inventors:

Curtis Priem - Freemont CA
Chris Malachowsky - Santa Clara CA
Peter Ross - Palo Alto CA

Assignee:

Sun Microsystems, Inc. - Mountain View CA

International Classification:

G06F 1568

US Classification:

395143

Abstract:

A computer graphics system comprising apparatus for drawing quadrilateral images on an output display when furnished the vertices of the quadrilateral, apparatus for providing width values for each end of a line to be displayed on an output display which width values are indirectly related to the depth of the ends of the line from the viewer, and apparatus for utilizing the width values to determine vertices of a line to be drawn by the apparatus for drawing a quadrilateral image.

US Patent:

42768985, Jul 7, 1981

Filed:

Jan 30, 1980

Appl. No.:

6/117008

Inventors:

Peter Ross - New York NY

Assignee:

Stop-A-Flat Corporation - Huntingdon Valley PA

International Classification:

F16K 1520
F16K 5100

US Classification:

137231

Abstract:

The delivery system functions under pump pressure to introduce a fluid such as a tire sealant interiorly of a pneumatic vessel such as a tire through the air valve without deflating the vessel. A valve core extractor functions in a pressurized atmosphere to remove and retain the valve core without loss of pressure. A pump including a resilient, one way check valve introduces the fluid through the valve, also without loss of pressure. Following introduction of the desired quantity of the fluid, the valve core extractor is functioned in reverse to reinsert the valve core, all without loss of system pressure.

US Patent:

48972606, Jan 30, 1990

Filed:

Feb 29, 1988

Appl. No.:

7/161743

Inventors:

Peter M. Ross - New York NY
H. Leon Bradlow - Holliswood NY

Assignee:

The Rockefeller University - New York NY

International Classification:

A61K 740
A61K 742
A61K 744
A61K 748

US Classification:

424 59

Abstract:

Glucocorticoid carboxylic acid esters and topical compositions thereof are utilized in methods for modulating cutaneous delayed hypersensitivity. Formulations of the glucocorticoid carboxylic acid esters are disclosed including incorporation into percutaneous drug delivery devices.